Jundishapur Journal of Microbiology

Published by: Kowsar

In-Vitro Evaluation of Antifungal Activity of Terbinafine and Terbinafine Nano-Drug Against Clinical Isolates of Dermatophytes

Nazila Motedayen 1 , Seyed Jamal Hashemi 2 , * , Sassan Rezaei 2 and Mansour Bayat 1
Authors Information
1 Department of Microbiology, Science and Research Branch, Islamic Azad University, Tehran, IR Iran
2 Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sceinces, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: May 2018, 11 (5); e62351
  • Published Online: April 17, 2018
  • Article Type: Research Article
  • Received: September 30, 2017
  • Revised: March 4, 2018
  • Accepted: March 15, 2018
  • DOI: 10.5812/jjm.62351

To Cite: Motedayen N, Hashemi S J, Rezaei S, Bayat M. In-Vitro Evaluation of Antifungal Activity of Terbinafine and Terbinafine Nano-Drug Against Clinical Isolates of Dermatophytes, Jundishapur J Microbiol. 2018 ; 11(5):e62351. doi: 10.5812/jjm.62351.

Abstract
Copyright © 2018, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusions
References
  • 1. Abd Elmegeed ASM, Ouf S, Moussa TA, Eltahlawi S. Dermatophytes and other associated fungi in patients attending to some hospitals in Egypt. Brazil J Microbiol. 2015;46(3):799-805. doi: 10.1590/S1517-838246320140615. [PubMed: 26413063].
  • 2. Cox RA. Immunology of the fungal diseases. CRC Press; 1989.
  • 3. Zamani S, Sadeghi G, Yazdinia F, Moosa H, Pazooki A, Ghafarinia Z, et al. Epidemiological trends of dermatophytosis in Tehran, Iran: A five-year retrospective study. J Mycol Med. 2016;26(4):351-8. doi: 10.1016/j.mycmed.2016.06.007. [PubMed: 27520535].
  • 4. Faure-Cognet O, Fricker-Hidalgo H, Pelloux H, Leccia MT. Superficial Fungal Infections in a French Teaching Hospital in Grenoble Area: Retrospective Study on 5470 Samples from 2001 to 2011. Mycopathologia. 2016;181(1-2):59-66. doi: 10.1007/s11046-015-9953-7. [PubMed: 26452757].
  • 5. Budak A, Bogusz B, Tokarczyk M, Trojanowska D. Dermatophytes isolated from superficial fungal infections in Krakow, Poland, between 1995 and 2010. Mycoses. 2013;56(4):422-8. doi: 10.1111/myc.12043. [PubMed: 23346893].
  • 6. Vena GA, Chieco P, Posa F, Garofalo A, Bosco A, Cassano N. Epidemiology of dermatophytoses: retrospective analysis from 2005 to 2010 and comparison with previous data from 1975. New Microbiol. 2012;35(2):207-13. [PubMed: 22707134].
  • 7. Roberts DT, Evans EG. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol. 1998;138(1):189-90. [PubMed: 9536247].
  • 8. Zhu M, Li L, Wang J, Zhang C, Kang K, Zhang Q. Tinea capitis in Southeastern China: a 16-year survey. Mycopathologia. 2010;169(4):235-9. doi: 10.1007/s11046-009-9260-2. [PubMed: 19936963].
  • 9. Fallahi AA, Rezaei-Matehkolaei A, Rezaei S. Epidemiological status of dermatophytosis in Guilan, north of Iran. Curr Med Mycol. 2017;3(1):20. doi: 10.29252/cmm.3.1.20. [PubMed: 29302626].
  • 10. Revankar SG, Graybill JR, Patterson TF. Antifungal Agents and Antifungal Susceptibility Testing. Topley Wilson's Microbiol Microb Infect. doi: 10.1002/9780470688618.taw0134.
  • 11. Mukherjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MA. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother. 2003;47(1):82-6. [PubMed: 12499173].
  • 12. Mendes AI, Silva AC, Catita JA, Cerqueira F, Gabriel C, Lopes CM. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity. Colloids Surf B Biointerfaces. 2013;111:755-63. doi: 10.1016/j.colsurfb.2013.05.041. [PubMed: 23954816].
  • 13. Gupta M, Vyas SP. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids. 2012;165(4):454-61. doi: 10.1016/j.chemphyslip.2012.01.006. [PubMed: 22309657].
  • 14. Azanza Perea JR, Barberan J. Anfotericina B forma liposómica: un perfil farmacocinético exclusivo. Una historia inacabada. Revista Espanola de Quimioterapia. 2012;25(1).
  • 15. Mozafari MR. Liposomes. Nanoliposomes: preparation and analysis. Springer; 2010. p. 29-50.
  • 16. John HR. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, approved standard. M38-A2. Clin Lab Stand Inst. 2008;16:1-35.
  • 17. White TJ, Thomas Bruns SJ, Lee WT, Taylor JL. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics." PCR protocols: a guide to methods and applications. 1990. Available from: http://msafungi.org/wp-content/uploads/Inoculum/64(1).pdf.
  • 18. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55(3):329-47. [PubMed: 12628320].
  • 19. Tang X, Zhu H, Sun L, Hou W, Cai S, Zhang R, et al. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo. Int J Nanomedicine. 2014;9:5403-13. doi: 10.2147/IJN.S71623. [PubMed: 25473279].
  • 20. Osborne CS, Leitner I, Hofbauer B, Fielding CA, Favre B, Ryder NS. Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine. Antimicrob Agents Chemother. 2006;50(6):2234-6. doi: 10.1128/AAC.01600-05. [PubMed: 16723593].
  • 21. Osborne CS, Leitner I, Favre B, Ryder NS. Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine. Antimicrob Agents Chemother. 2005;49(7):2840-4. doi: 10.1128/AAC.49.7.2840-2844.2005. [PubMed: 15980358].
  • 22. Paiao FG, Segato F, Cursino-Santos JR, Peres NT, Martinez-Rossi NM. Analysis of Trichophyton rubrum gene expression in response to cytotoxic drugs. FEMS Microbiol Lett. 2007;271(2):180-6. doi: 10.1111/j.1574-6968.2007.00710.x. [PubMed: 17425668].
  • 23. Sharma S, Sharma U. Synthesis, characterization and determination of encapsulation efficiency of chitosan nanoparticles for terbinafine. Indo Am J Pharm Res. 2013;3(12):1564-7.
  • 24. Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits. AAPS PharmSciTech. 2013;14(2):782-93. doi: 10.1208/s12249-013-9964-y. [PubMed: 23615773].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments